The Peters Plan to benefit himself is the most successful thing he’s done in Congress
LANSING, Mich., October 14, 2020 – U.S. Senator Gary Peters talks a lot about the American health care system but a look at U.S. Senate and Federal Election Commission data shows his plan for flooding his campaigns and wallet with healthy doses of drug company cash is one of the most successful things he’s ever done.
The Peters Plan for soliciting and accepting thousands of dollars from pharmaceutical companies, while claiming on television that he is fighting them, has been very effective.
Peters’ various political committees have taken a whopping $194,000 from drug company corporate and employee PACs since he entered Congress.
The Peters Plan has also helped create a healthy bottom line for Peters’ personal wealth.
Peters doubled his personal wealth while in Washington, D.C., and he did it in part with his plan to bet big on drug companies profiting off patients.
Peters reports thousands of dollars in personal income as a result of his holdings in major drug companies, per financial disclosures in Congress:
- Abbott Laboratories: Between $2,012 and $10,600
- AbbVie: Between $2,609 and $10,500
- Bristol-Myers Squibb: Between $2,412 and $12,000
- Merck: Between $2,412 and $12,000
- Pfizer: Between $2,412 and $12,000
- Teva Pharmaceuticals: Between $1,001 and $5,000
“Gary Peters has not been successful at much in Washington. But with The Peters Plan, Gary got ahead with the help of drug companies and generated healthy profits for himself,” said Michigan Republican Party Chairman Laura Cox. “It’s no wonder voters have been left this year to wonder what it is Peters did for them.”